# Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/capecitabine-and-temozolomide-captem-for-metastatic-well-differentiated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert L. Fine,Anthony P. Gulati,Benjamin A. Krantz,Rebecca A. Moss,Stephen M. Schreibman,Dawn Tsushima,Kelley B. Mowatt,Richard D. Dinnen,Yuehua Mao,Peter D. Stevens,Beth Schrope,John Allendorf,James A. Lee,William H. Sherman,John A. Chabot |
| Citations | 257 |
| DOI | 10.1007/s00280-012-2055-z |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2008997722 |
| PMID | 23370660 |
| Type | article |
| Year | 2013 |

## Paper authors

- [James A. Lee](https://scholariq.org/researchers/james-a-lee/)

## Paper primary topic

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Paper topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Thyroid Cancer Diagnosis and Treatment](https://scholariq.org/topics/thyroid-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.